We are committed to protecting the health of expectant mothers, babies, and families. For these reasons, we provide a complete portfolio of screening, diagnostic, medical imaging and treatment systems that go a long way toward ensuring a pro-active approach to healthcare.
We are focused on pioneering work in prenatal risk assessment and neonatal screening; delivering next-generation instrumentation and diagnostic capabilities; and providing cord-blood stem-cell banking services. Our advances in digital imaging technology address some of the most demanding X-ray applications to enable oncology, cardiovascular and neurovascular imaging systems. We are also bringing infectious disease diagnostics to China delivering safety and peace of mind at affordable price points.
Learn how we help to protect expectant mothers and their fetuses.
See how we’re providing families with disorder identification enabling earlier medical intervention.
Read how we help protect both patients and communities from diseases such as HIV.
Learn about its potential medical or therapeutic use for children or related family members.
As the nation's largest provider of newborn screening services, PerkinElmer Genomics is dedicated to improving the lives of children and their families by offering early detection of metabolic and other inherited disorders.